At the end of the twentieth century, a specific autoantibody against AT1 receptor (AT1-AA) has been discovered and was found to exist in patients with preeclampsia [13], malignant hypertension [14], refractory hypertension [15] and renal-allograft rejection [16]. This evidence concerns the gene AGTR1 and malignant hypertension.